Innovative Herpes Virus-Based Vaccine Shows Potential in Cancer Treatment Without Side Effects
A novel herpes virus-based cancer vaccine shows promise in targeting tumors effectively without causing side effects, offering new hope for cancer therapies.
A groundbreaking study from Åbo Akademi University in Finland reveals that genetically modified herpes simplex virus can be engineered to act as an effective and safe cancer vaccine. Herpes simplex virus, commonly known for causing cold sores, is present in most individuals. Researchers have identified that by removing a specific virulence gene, which typically makes the virus harmful, the virus can be repurposed to target and destroy cancer cells without damaging healthy tissues.
This innovative approach involves inserting a gene that encodes decorin, a crucial protein involved in connective tissue regulation, wound healing, and blood vessel formation. Notably, decorin is often absent in many human cancers, including those characterized by excessive blood vessel growth or angiogenesis, which can hinder the effectiveness of traditional treatments. By restoring decorin expression within the vaccine, the therapy aims to inhibit tumor blood vessel formation, thereby starving the cancer and making it more susceptible to treatment.
Verifying its efficacy, the research demonstrated that decorin-enhanced vaccines significantly boosted the killing of lung cancer cells. Furthermore, these vaccines can be administered intranasally, which was successfully tested on mice, providing a less invasive delivery method. Remarkably, in chicken embryo models of liver cancer, the vaccine reduced tumor-associated blood vessel growth by 40%, with treated tumors developing normal vasculature, even after blood vessel formation had started. Importantly, no adverse side effects were observed, indicating the vaccine's specificity and safety.
Overall, these findings suggest a promising future for cancer vaccines that are not only effective but also free of side effects. By targeting blood vessel growth around tumors, such vaccines could improve drug delivery and treatment outcomes, potentially complementing existing therapies. This research paves the way for new, less invasive, and safer cancer treatment options.
Source: https://medicalxpress.com/news/2025-10-herpes-virus-based-vaccine-tumors.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Approaches to Combat Kidney Disease by Targeting Neutrophils
Emerging research reveals how targeted therapies against neutrophils and NETs could revolutionize treatment for various kidney diseases, reducing inflammation and tissue damage.
The Role of Continuous Support in Maintaining Weight Loss Post-Diet
Ongoing support plays a vital role in helping individuals maintain weight loss over time. A recent study finds that regular contact is effective, and personalized schedules may not offer additional benefits. Learn more about long-term obesity management strategies.
Majority of Americans Believe Alcohol Is Harmful to Health: New Poll Findings
A new Gallup survey shows that most Americans now view moderate alcohol consumption as harmful, with declining drinking rates and increased awareness of health risks. Learn more about the changing perceptions and health implications of alcohol use.
